The Serum Institute to release India’s first indigenous HPV vaccine to combat cervical cancer.

The Serum Institute of India (SII) intends to offer the HPV vaccine in November of this year.

The Serum Institute of India (SII) intends to offer the country's first indigenous human papillomavirus (HPV) vaccine in November of this year. The decision was reportedly made after the National Technical Advisory Group on Immunization (NTAGI) suggested to the Union health ministry that HPV vaccine be included in the National Immunization Program.

According to reports the Cervical cancer is a cancer of the cervix or the lower-most section of the uterus that can be prevented with screening and the HPV vaccine.

After breast, lung, and colorectal cancer, cervical cancer is the fourth most frequent malignancy in women. Despite its high frequency, the condition is poorly understood in India, with many people equating it with cervical neck cancer.

The Serum Institute of India (SII) intends to offer the country's first indigenous human papillomavirus (HPV) vaccine in November of this year. The decision was reportedly made after the National Technical Advisory Group on Immunization (NTAGI) suggested to the Union health ministry that HPV vaccine be included in the National Immunization Program. Cervical cancer is a cancer of the cervix or the lower-most section of the uterus that can be prevented with screening and the HPV vaccine, according to reports.

After breast, lung, and colorectal cancer, cervical cancer is the fourth most frequent malignancy in women. Despite its high frequency, the condition is overlooked in India, with many people equating it with cervical neck cancer.